Literature DB >> 19631234

Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease.

Laura D Kubzansky1, Gail K Adler.   

Abstract

Numerous studies support the notion that cumulative exposure to chronic stress is a risk factor for cardiovascular disease (CVD). Various stress-related hormones have been proposed as potential mediators of the relationship between psychological stress and CVD, including catecholamines and more indirectly, cortisol. Somewhat surprisingly, although aldosterone is also released in response to hypothalamic-pituitary-adrenal (HPA) axis activation, it has not been considered as relevant for this relationship. In the present review we will consider aldosterone as a potentially important mediator of the relationship between negative affective states and CVD. First, we will briefly review the known functions and roles of aldosterone, and then consider its actions in both the brain and the periphery. We will then review the available literature on the role of aldosterone in CVD, and also consider links between aldosterone and various forms of chronic psychological stress. Finally we will present an integrated model of how aldosterone may mediate effects of chronic stress on CVD, recommend new directions for research, and identify important methodological and design issues for this work.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631234      PMCID: PMC3099453          DOI: 10.1016/j.neubiorev.2009.07.005

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  85 in total

1.  Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.

Authors:  Diego V Martinez; Ricardo Rocha; Mamiko Matsumura; Eveline Oestreicher; Margarita Ochoa-Maya; Weranuj Roubsanthisuk; Gordon H Williams; Gail K Adler
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

Review 2.  Body fat distribution, insulin resistance, and metabolic diseases.

Authors:  P Björntorp
Journal:  Nutrition       Date:  1997-09       Impact factor: 4.008

3.  Role for aldosterone in blood pressure regulation of obese adolescents.

Authors:  A P Rocchini; V L Katch; R Grekin; C Moorehead; J Anderson
Journal:  Am J Cardiol       Date:  1986-03-01       Impact factor: 2.778

Review 4.  Aldosterone as a cardiovascular risk hormone.

Authors:  Takanobu Yoshimoto; Yukio Hirata
Journal:  Endocr J       Date:  2007-04-03       Impact factor: 2.349

5.  Stress reduction and preventing hypertension: preliminary support for a psychoneuroendocrine mechanism.

Authors:  K G Walton; N D Pugh; P Gelderloos; P Macrae
Journal:  J Altern Complement Med       Date:  1995       Impact factor: 2.579

6.  Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes.

Authors:  D Kraus; J Jäger; B Meier; M Fasshauer; J Klein
Journal:  Horm Metab Res       Date:  2005-07       Impact factor: 2.936

Review 7.  Brain corticosteroid receptor balance in health and disease.

Authors:  E R De Kloet; E Vreugdenhil; M S Oitzl; M Joëls
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

8.  Aldosterone induces superoxide generation via Rac1 activation in endothelial cells.

Authors:  Fumiko Iwashima; Takanobu Yoshimoto; Isao Minami; Maya Sakurada; Yuki Hirono; Yukio Hirata
Journal:  Endocrinology       Date:  2007-12-13       Impact factor: 4.736

9.  Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.

Authors:  Christine Guo; Vincent Ricchiuti; Bill Q Lian; Tham M Yao; Patricia Coutinho; José R Romero; Jianmin Li; Gordon H Williams; Gail K Adler
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

10.  Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study.

Authors:  M Ashraf Ganie; M L Khurana; M Eunice; N Gupta; M Gulati; S N Dwivedi; A C Ammini
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

View more
  29 in total

1.  ACTH Infusion Impairs Baroreflex Sensitivity-Implications for Cardiovascular Hypoglycemia-Associated Autonomic Failure.

Authors:  Janet H Leung; Omar F Bayomy; Istvan Bonyhay; Johanna Celli; Jeffrey White; Roy Freeman; Gail K Adler
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

2.  Anesthesia with sevoflurane in neonatal rats: Developmental neuroendocrine abnormalities and alleviating effects of the corticosteroid and Cl(-) importer antagonists.

Authors:  Changqing Xu; Sijie Tan; Jiaqiang Zhang; Christoph N Seubert; Nikolaus Gravenstein; Colin Sumners; Terrie Vasilopoulos; Anatoly E Martynyuk
Journal:  Psychoneuroendocrinology       Date:  2015-06-25       Impact factor: 4.905

Review 3.  Autonomic and inflammatory consequences of posttraumatic stress disorder and the link to cardiovascular disease.

Authors:  Chevelle Brudey; Jeanie Park; Jan Wiaderkiewicz; Ihori Kobayashi; Thomas A Mellman; Paul J Marvar
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-06-10       Impact factor: 3.619

4.  The use of health impact assessment for a community undergoing natural gas development.

Authors:  Roxana Z Witter; Lisa McKenzie; Kaylan E Stinson; Kenneth Scott; Lee S Newman; John Adgate
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

Review 5.  Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies.

Authors:  Allan Doctor; Jerry Zimmerman; Michael Agus; Surender Rajasekaran; Juliane Bubeck Wardenburg; James Fortenberry; Anne Zajicek; Emma Mairson; Katri Typpo
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

6.  A prospective study of positive psychological well-being and coronary heart disease.

Authors:  Julia K Boehm; Christopher Peterson; Mika Kivimaki; Laura Kubzansky
Journal:  Health Psychol       Date:  2011-05       Impact factor: 4.267

7.  Genome-wide DNA methylation investigation of glucocorticoid exposure within buccal samples.

Authors:  Patricia R Braun; Mai Tanaka-Sahker; Aubrey C Chan; Sydney S Jellison; Mason J Klisares; Benjamin W Hing; Yaseen Shabbir; Lindsey N Gaul; Yasunori Nagahama; Julian Robles; Jonathan T Heinzman; Sayeh Sabbagh; Ellyn M Cramer; Gabrielle N Duncan; Kumi Yuki; Liesl N Close; Brian J Dlouhy; Matthew A Howard; Hiroto Kawasaki; Kyle M Stein; James B Potash; Gen Shinozaki
Journal:  Psychiatry Clin Neurosci       Date:  2019-03-28       Impact factor: 5.188

8.  A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism.

Authors:  G A Kline; J L Pasieka; A Harvey; B So; V C Dias
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

9.  Potentially traumatic events and the risk of six physical health conditions in a population-based sample.

Authors:  Katherine M Keyes; Katie A McLaughlin; Ryan T Demmer; Magdalena Cerdá; Karestan C Koenen; Monica Uddin; Sandro Galea
Journal:  Depress Anxiety       Date:  2013-03-11       Impact factor: 6.505

10.  Endocrine and neurobehavioral abnormalities induced by propofol administered to neonatal rats.

Authors:  Sijie Tan; Changqing Xu; Wanting Zhu; Jesse Willis; Christoph N Seubert; Nikolaus Gravenstein; Colin Sumners; Anatoly E Martynyuk
Journal:  Anesthesiology       Date:  2014-11       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.